On October 17, 2017, the Company announced that it had reached a definitive agreement for Amneal to acquire all outstanding shares of IPXL in a stock-for-stock transaction. WeissLaw is investigating whether IPXL's Board acted to …
A covered call identified by MarketIntelligececenter.com's patented algorithm on Impax Labs Inc (IPXL) could yield about 7.14% (13.57% annualized, for comparison purposes only) in 192 days. Pair a long position in the stock with the Jun …
As alluded to, IPXL has put in a strong showing today, with the drug stock last seen 4.5% higher at $33.99. Historically speaking, this is unusual. The shares have surrendered more than one-fifth of their value in 2016, and late last month hit …
On October 17, 2017, the Company announced that it had reached a definitive agreement for Amneal to acquire all …
On October 17, 2017, the Company announced that it had reached a definitive agreement for Amneal to acquire all …
WIS-TV1mon